Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Emergent Biosolutions, Inc. (EBS)

NYSE

$6,37

$+0,14

(+2,23%)

Pre-Market

Emergent Biosolutions, Inc. (EBS) Live Price Chart

Last updated: ⁦2026-09-16 12:10:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Emergent Biosolutions, Inc. (EBS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $6,37, with a market capitalisation of $327,12M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4,36 to $14,06. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$327,12M
Open	$6,23
Day's High	$137,61
Day's Low	$1,42
Previous Close	$6,36
Volume	4,00
Average Volume	1,13M
P/E Ratio	--
52-Week High	$14,06
52-Week Low	$4,36
Dividend Yield	--
Earnings Date	--

Emergent Biosolutions, Inc. (EBS) Pre-Market Stock Price

Emergent Biosolutions, Inc. (EBS) is trading at $6,37 in pre-market trading as of 2026-09-16 11:16:00, up 0,08% ($0,00) from the previous close of $6,36

Pre-market trading shows how investors are pricing EBS before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Emergent Biosolutions, Inc. (EBS) 7-Day Stock Price Change

Over the past seven days, Emergent Biosolutions, Inc. (EBS) moved from $6,21 to $6,37, representing a gain of 2,50% ($0,16).

The stock traded between $5,50 and $6,50 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 1,18 million shares, up versus the previous seven-day period, indicating higher trading activity.

EBS 52-Week Price Position

Position in Range: 20,7%

52W Low$4,36

52W High$14,06

EBS is currently trading at $6,37, placing it 20,7% of the way from its 52-week low of $4,36 to its 52-week high of $14,06. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Emergent Biosolutions, Inc. (EBS)?

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Emergent Biosolutions, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	900
Exchange	NYSE
Company Website	https://www.emergentbiosolutions.com

How to Buy Emergent Biosolutions, Inc. (EBS) Stock on MEXC

Eligible investors can buy real shares of Emergent Biosolutions, Inc. (EBS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for EBS and Place Your Order

Open the RealStocks trading page and search for EBS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Emergent Biosolutions, Inc. (EBS) stock price today?

Emergent Biosolutions, Inc. (EBS) is currently trading at $ 6,37, up 0,08% ($0,00) from the previous close of $ 6,36. Intraday prices update in real time during regular trading hours.

2.Is EBS stock going up or down today?

As of 2026-09-16 11:16:00, EBS is trading at $ 6,37, up 0,08% ($0,00) from its previous close of $ 6,36. The stock has traded between $ 1,42 and $ 137,61 during today’s regular session. Past price movements do not guarantee future results.

3.What is EBS pre-market price?

As of 2026-09-16 11:16:00, EBS is trading at $ 6,37 in pre-market trading, up 0,08% ($0,00) from the previous close of $ 6,36. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is EBS after-hours price?

As of 2026-09-16 11:16:00, EBS is trading at $ 6,21 in after-hours trading, down 2,31% ($0,15) from the regular-session close of $ 6,36. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is EBS stock trading now?

EBS trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does EBS sit relative to its 52-week high and low?

Over the past 52 weeks, EBS has traded between a low of $ 4,36 and a high of $ 14,06. At $ 6,37, the stock is positioned 20,7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Emergent Biosolutions, Inc. in?

Emergent Biosolutions, Inc. (EBS) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Emergent Biosolutions, Inc.'s market capitalisation and where is it listed?

Emergent Biosolutions, Inc. is listed on the NYSE exchange with a market capitalisation of $ 327,12M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is EBS valued in terms of P/E ratio and EPS?

EBS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3,45. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Emergent Biosolutions, Inc. pay a dividend?

Emergent Biosolutions, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.